Mash Ka Wisen Treatment Center

1150 Mission Road, Cloquet, MN 55720

Mash Ka Wisen Treatment Center is a residential facility in Cloquet, MN offering substance use treatment. Buprenorphine and Naltrexone are used for opioid use disorder. It reports accepting self-payment, Medicaid, and private insurance.

Licenses and accreditations

Commission on Accreditation of Rehabilitation Facilities (CARF)Accredited by CARF, an independent nonprofit accreditor of health and human services.

Kinds of care

Substance use treatment: Treatment for alcohol and drug use.

Settings

Long-term residential: Living at the facility for more than 30 days.
Residential/24-hour residential: Living at the facility during treatment.
Short-term residential: Living at the facility for 30 days or less.

Medications for opioid use

Buprenorphine used in Treatment: Buprenorphine is used here.
Naltrexone used in Treatment: Naltrexone is used here.

Accepts clients using MAT but prescribed elsewhere: Accepts clients whose medication for opioid use is prescribed elsewhere.
Buprenorphine maintenance: Buprenorphine continued over time to prevent relapse.
Prescribes buprenorphine: Prescribes buprenorphine.
Prescribes naltrexone: Prescribes naltrexone.

Payment

Accepted: Cash or self-payment; Federal, state, or local government funding for substance use treatment; Indian Health Service, tribal, or urban Indian health funds; Medicaid; Private health insurance; A state-financed health insurance plan other than Medicaid.

Who they serve

Ages served: Adults, 26 to 64; Seniors, 65 and older; Young adults, 18 to 25.
Sex: Female; Male.

More details this facility reports

External Opioid Medications Source: In-network prescribing entity; Other contracted prescribing entity.
Type of Alcohol Use Disorder Treatment: Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder.
External Source of Medications Used for Alcohol Use Disorder Treatment: In-network prescribing entity; No formal relationship with prescribing entity; Other contracted prescribing entity.
Pharmacotherapies: Acamprosate (Campral®); Buprenorphine with naloxone; Buprenorphine without naloxone; Medication for mental disorders; Naltrexone (extended-release, injectable); Naltrexone (oral).
Treatment Approaches: 12-step facilitation; Anger management; Brief intervention; Cognitive behavioral therapy; Matrix Model; Motivational interviewing; Relapse prevention; Substance use disorder counseling; Trauma-related counseling.
Facility Operation (e.g., Private, Public): Private non-profit organization.
Assessment/Pre-treatment: Comprehensive substance use assessment; Outreach to persons in the community; Screening for substance use; Screening for tobacco use.
Testing: Breathalyzer or blood alcohol testing; Drug and alcohol oral fluid testing; Drug or alcohol urine screening; HIV testing; STD testing; TB screening; Testing for Hepatitis B (HBV); Testing for Hepatitis C (HCV).
Transitional Services: Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge.
Recovery Support Services: Assistance with obtaining social services; Mentoring/peer support; Self-help groups.
Education and Counseling Services: Family counseling; Group counseling; HIV or AIDS education, counseling, or support; Health education services other than HIV/AIDS or hepatitis; Hepatitis education, counseling, or support; Individual counseling; Substance use disorder education.
Facility Smoking Policy: Smoking permitted in designated area.
Facility Vaping Policy: Vaping not permitted.
Ancillary Services: Case management service; Mental health services; Social skills development; Suicide prevention services; Transportation assistance.

Details are as the facility reported them to the public record. Call the facility to confirm services, availability, and coverage before you go. Something wrong here? Report a problem with this listing.